Differential tumor surveillance by natural killer (NK) and NKT cells

Journal of Experimental Medicine

Volumn 191, Issue 4, 2000, Pages 661-668

  Smyth, Mark J ^a   Thia, Kevin Y T ^a   Street, Shayna E A ^a   Cretney, Erika ^a   Trapani, Joseph A ^a   Taniguchi, Masaru ^b   Kawano, Tetsu ^b   Pelikan, Sonja B ^c   Crowe, Nadine Y ^c   Godfrey, Dale I ^c  

^a AUSTIN RESEARCH INSTITUTE   (Australia)

^b CHIBA UNIVERSITY   (Japan)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Carcinogen; Interleukin 12; Natural killer T cells; Perforin; Tumor immunity

Indexed keywords

3 METHYLCHOLANTHRENE; CARCINOGEN; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE TARGETING; IMMUNE RESPONSE; IMMUNE STATUS; IMMUNOSURVEILLANCE; LYMPHOCYTE SUBPOPULATION; METASTASIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR IMMUNITY; TUMOR REJECTION;

ANIMALS; CROSSES, GENETIC; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GALACTOSYLCERAMIDES; GENES, T-CELL RECEPTOR ALPHA; INTERLEUKIN-12; KILLER CELLS, NATURAL; LIVER; MALE; METHYLCHOLANTHRENE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASMS, EXPERIMENTAL; RECEPTOR-CD3 COMPLEX, ANTIGEN, T-CELL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTE SUBSETS; THYMUS GLAND; TUMOR CELLS, CULTURED;

EID: 0034695880     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.191.4.661     Document Type: Article

References (46)

1. Biology of natural killer cells
2. Role of NK cells in tumour growth and metastasis in beige mice
3. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy
4. NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection
5. Mouse CD1-specific NK1 T cells: Development, specificity, and function
6. - αβ T cells in the peritoneal cavity: Specific T cell receptor-mediated cytotoxicity and selective IFN-γ production against B cell leukemia and myeloma cells
7. + cells: New clues to their origin, specificity, and function
8. - T cells in mice and humans
9. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors
10. Essential requirement of an invariant Vα14 T cell antigen receptor expression in the development of natural killer T cells
11. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides
12. + NK T lymphocytes
13. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells
14. + thymocytes selected by MHC class I molecules
15. + cells in the liver of mice
16. + T cells in a TH2 response and in immunoglobulin E production
17. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells
18. NKT cells are a phenotypically and functionally diverse population
19. - T cells produce IL-4
20. - thymocytes with specific lymphokine secretion
21. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells
22. + thymocyte population associated with intact Fas antigen expression on the target
23. -cells
24. T cell receptor complexes containing FcεRl gamma homodimers in lieu of CD3 ζ and CD3 ζ components: A novel isoform expressed on large granular lymphocytes
25. NKR-P1, an activating molecule on rat natural killer cells, stimulates phosphoinositide turnover and a rise in intracellular calcium
26. Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen. IL-2-activated NK cells possess additional specific stimulation pathways
27. + T cells upon NKR-P1 cross-linking
28. + αβ T cells with intermediate TCR induced in the liver of mice by IL-12
29. + T cells in IL-12-induced immune responses in vivo
30. + αβ T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells
31. KRN7000, a novel immunomodulator, and its antitumor activities
32. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells
33. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells
34. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice
35. IL-12 deficient mice are defective in IFN-γ production and type I cytokine responses
36. An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum
37. Perforin is the major contributor to NK cell control of tumor metastasis
38. Decreased tumor surveillance in perforin-deficient mice
39. Demonstration of an interferon γ-dependent rumor surveillance system in immunocompetent mice
40. Effect of interleukin 12 on tumor induction by 3-methylcholanthrene
41. Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo
42. Induction of dendritic cells (DC) by Flt3 ligand (FL) promotes the generation of tumor-specific immune responses in vivo
43. Chemically induced sarcomas from nude mice are more immunogenic than similar sarcomas from congenic normal mice
44. Antitumor and antimetastatic activity of interleukin 12 against murine tumors
45. Perforin-dependent NK cell cytotoxicity is sufficient for anti-metastatic effect of IL-12
46. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells